ANI Pharmaceuticals, Inc. (ANIP)
74.21
-1.75
(-2.30%)
USD |
NASDAQ |
Apr 02, 16:00
74.26
+0.06
(+0.07%)
After-Hours: 20:00
ANI Pharmaceuticals Accounts Receivable (Annual) : 281.08M for Dec. 31, 2025
Accounts Receivable (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Annual) Benchmarks
| Liquidia Corp. | 54.09M |
| Catalyst Pharmaceuticals, Inc. | 126.48M |
| Indivior Pharmaceuticals, Inc. | 253.00M |
| Replimune Group, Inc. | -- |
| ADMA Biologics, Inc. | 158.43M |